MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

105.25

-0.38%↓

WBA

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

105.25

-0.38%↓

WBA

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

105.25

-0.38%↓

WBA

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

105.25

-0.38%↓

WBA

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

105.25

-0.38%↓

WBA

+0.36%↑

CHE

545.53

-2.68%↓

Home・Aandelen Lijst・Novavax Inc

Novavax Inc

Open

SectorGezondheidszorg

7.07

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

6.81

Max

7.09

Belangrijke statistieken
By Trading Economics
Inkomsten	40M -81M
Verkoop	3.8M 88M
EPS	-0.52
Winstmarge	-91.755
Werknemers	952
EBITDA	52M -53M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+101.56% upside

Dividenden
By Dow Jones
Volgende Winsten	9 mei 2025

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-299M 967M
Vorige openingsprijs	7.07
Vorige sluitingsprijs	7.07

Technische score

By Trading Central

Vertrouwen

Very Strong Bullish Evidence

5.6 / 6.467 Steun & Weerstand

Novavax Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

2 apr 2025, 17:06 UTC

Belangrijke Marktbewegers

Novavax Falls But Then Recovers After WSJ Report on Vaccine's FDA Status

31 mrt 2025, 14:19 UTC

Belangrijke Marktbewegers

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

4 feb 2025, 18:52 UTC

Belangrijke Marktbewegers

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

11 nov 2024, 14:05 UTC

Belangrijke Marktbewegers

Novavax to Move Forward With Covid-19, Influenza Vaccine After FDA Lifts Clinical Hold

16 okt 2024, 12:59 UTC

Belangrijke Marktbewegers

Novavax Says FDA Puts Clinical Hold on Covid-19, Flu Vaccines; Shares Drop

13 mei 2024, 18:14 UTC

Belangrijke Marktbewegers

Novavax Shares Pop Another 50% Following Sanofi Deal

10 mei 2024, 10:59 UTC

Belangrijke Marktbewegers

Novavax Shares Surge on $1.4 Billion Vaccine Licensing Deal with Sanofi

30 dec 2024, 23:02 UTC

Acquisities, Fusies, Overnames

Novavax Completes Previously Announced $200M Sale of Czech Republic Manufacturing Site to Novo Nordisk

4 dec 2024, 07:09 UTC

Acquisities, Fusies, Overnames

Novavax: Agreement to Close by Dec 30 >NVAX

4 dec 2024, 07:08 UTC

Acquisities, Fusies, Overnames

Novavax: Sale Aligns With Plan to Become More Lean Organization, Drive Value From Pipeline Assets & Tech Platform >NVAX

4 dec 2024, 07:07 UTC

Acquisities, Fusies, Overnames

Novavax: Deal to Also Reduce Annual Operating Costs by About $80M >NVAX

4 dec 2024, 07:06 UTC

Acquisities, Fusies, Overnames

Novavax to Get $190M Cash Payment in 2024, Additional $10M in 2025 >NVAX

4 dec 2024, 07:06 UTC

Acquisities, Fusies, Overnames

Novavax: Agreement Provides Company With Significant, Non-Dilutive Capital >NVAX

4 dec 2024, 07:04 UTC

Acquisities, Fusies, Overnames

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200M

15 nov 2024, 13:34 UTC

Top Nieuws

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ

15 nov 2024, 11:14 UTC

Marktinformatie

U.S. Vaccine Stocks Fall After Trump Picks Vaccine Skeptic RFK Jr as Health Department Head-- Market Talk

16 okt 2024, 15:22 UTC

Winsten

These Stocks Are Moving the Most Today: ASML, Nvidia, Morgan Stanley, United Airlines, DJT, Novavax, J.B. Hunt, Cisco, and More -- Barrons.com

10 mei 2024, 20:11 UTC

Winsten

These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital, JFrog, SoundHound, and More -- Barrons.com

10 mei 2024, 14:49 UTC

Winsten

Populaire aandelen

Stocks to Watch Friday: TSMC, Novavax, Nvidia -- WSJ

10 mei 2024, 10:47 UTC

Acquisities, Fusies, Overnames

Novavax Gets $1.4 Billion Deal With Sanofi. The Stock Jumps. -- Barrons.com

Peer Vergelijking

Prijswijziging

Novavax Inc Prognose

Koersdoel

By TipRanks

101.56% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 14.25 USD 101.56%

Hoogste 19 USD

Laagste 9 USD

Gebaseerd op 4 Wall Street-analisten die 12-maands prijsdoelen bieden voor Novavax Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

4 ratings

Buy

Hold

Sell

Gebaseerd op 4 analisten die aandelenratings hebben gegeven aan Novavax Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

5.6 / 6.467Steun & Weerstand

Recent bullish events outweigh bearish events.

All events are bearish.

Bearish events outweigh bullish events.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.